Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
100%(1 trials)
Terminated
1(33%)

Phase Distribution

Ph phase_1
2
67%

Phase Distribution

2

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
Phase 1Safety & dosage
2(100.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Completed(1)
Terminated(1)

Detailed Status

Completed1
Enrolling by invitation1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
50.0%
Most Advanced
Phase 1

Trials by Phase

Phase 12 (100.0%)

Trials by Status

completed133%
enrolling_by_invitation133%
terminated133%

Recent Activity

0 active trials
Showing 3 of 3
terminatedphase_1

A Study of FT 4101 in Overweight/Obese Participants With Non-alcoholic Steatohepatitis

NCT04004325
enrolling_by_invitation

Elucidating Hepatic Metabolism in Non-alcoholic Fatty Liver Disease

NCT06942312
completedphase_1

A Study to Evaluate a Skeletal-muscle Microbiopsy Technique With Dynamic Proteomic Measurement in Healthy Male Volunteers

NCT01962454

Clinical Trials (3)

Showing 3 of 3 trials
NCT04004325Phase 1

A Study of FT 4101 in Overweight/Obese Participants With Non-alcoholic Steatohepatitis

Terminated
NCT06942312

Elucidating Hepatic Metabolism in Non-alcoholic Fatty Liver Disease

Enrolling By Invitation
NCT01962454Phase 1

A Study to Evaluate a Skeletal-muscle Microbiopsy Technique With Dynamic Proteomic Measurement in Healthy Male Volunteers

Completed

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3